心脏衰竭与减少的喷射率和COVID-19,当病人变得更生病:揭露在流行病期间的种族和种族不平等
Johanna Contreras1, Elizabeth O Tinuoye1, Alejandro Folch1
1Division of Cardiovascular Medicine, The Mount Sinai Health System, 1190 5th Avenue, 1st Floor, New York, NY 10029, USA.
Heart failure clinics
|August 31, 2024
概括
尽管医学的进步,心力衰竭的种族和民族差异仍然存在. COVID-19大流行突显了健康的社会决定因素如何加剧这些不平等,为改善医疗保健公平提供了机会.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 健康 公平 卫生 公平
背景情况:
- 少数种族和民族群体经历了不成比例的高心力衰竭发病率,流行率和住院治疗.
- 尽管心力衰竭治疗方面取得了进展,但这些人群的发病率和死亡率仍然很高.
- 导致这些差异的因素包括健康的社会决定因素 (SDOH),如有限的护理机会,隐含的偏见和结构性种族主义.
研究的目的:
- 审查从COVID-19大流行中学到的关于心力衰竭差异的教训.
- 探索心力衰竭,健康的社会决定因素和种族/民族不平等的交集.
- 确定促进弱势群体健康平等的机会.
主要方法:
- 文献综述和现有研究的综合.
- 分析COVID-19大流行对健康差异的影响.
- 检查健康的社会决定因素在心力衰竭结果中的作用.
主要成果:
- COVID-19 流行病加剧了现有的健康不平等,特别是在心力衰竭的少数群体中.
- SDOH被确定为心力衰竭护理和结果差异的关键驱动因素.
- 疫情凸显了迫切需要解决影响弱势群体的系统因素的迫切需要.
结论:
- 解决健康的社会决定因素对于减少心力衰竭差异至关重要.
- COVID-19 流行病为实施系统性变革提供了一个独特的机会,以实现更大的医疗保健公平.
- 需要针对性干预,重点关注获取,减少偏见和反种族主义,以改善所有人的心力衰竭结果.
更多相关视频
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
01:22Heart Failure Drugs: β-Blockers
322
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
322
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352